Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antibacterial activity against Salmonella newport clinical isolate after 24 hrs by liquid growth inhibition assay
Assay data:1 Active, 1 Activity ≤ 1 µM, 3 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Bactericidal activity against Salmonella newport clinical isolate after 24 hrs
Assay data:2 Tested
SummaryPubMed Citation
Inhibition of oxygen consumption in Salmonella newport clinical isolate at 30 uM after 35 mins by Gilson Clarke oxygraph analysis
Assay data:1 Tested
Antibacterial activity against Salmonella newport clinical isolate up to 250 uM after 24 hrs by liquid growth inhibition assay
Assay data:4 Tested
Inhibition of oxygen consumption in Salmonella newport clinical isolate at 0.25 uM after 35 mins by Gilson Clarke oxygraph analysis
Assay data:1 Active, 1 Tested
SummaryCompounds, ActivePubMed Citation
Inhibition of oxygen consumption in Salmonella newport clinical isolate at 25 uM after 35 mins by Gilson Clarke oxygraph analysis
Inhibition of Salmonella enterica serotype Newport AM17274 cephalosporinase CMY-31 by UV spectrophotometer in presence of 100 uM of cephalothin
Assay data:3 Active, 3 Activity ≤ 1 µM, 3 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Activity of Salmonella enterica serotype Newport AM17274 cephalosporinase CMY-31 by spectrophotometry
Assay data:4 Active, 2 Activity ≤ 1 µM, 6 Tested
Antimicrobial activity against Salmonella Newport 03-8748 by Etest
Antibacterial activity against Salmonella enterica serovar Newport assessed as percent resistant isolates by broth microdilution method in presence of sulfamethoxazole
Antibacterial activity against Salmonella enterica serovar Newport assessed as percent susceptible isolates by broth microdilution methods in presence of sulfamethoxazole
Antibacterial activity against Salmonella enterica serovar Newport by broth microdilution method in presence of sulfamethoxazole
Antibacterial activity against Salmonella enterica serovar Newport assessed as percent resistant isolates by broth microdilution method
Assay data:5 Tested
Antibacterial activity against Salmonella enterica serovar Newport assessed as percent susceptible isolates by broth microdilution method
Antibacterial activity against Salmonella enterica serovar Newport by broth microdilution method
Assay data:6 Tested
Ratio of Kcat to Km for Salmonella enterica serotype Newport AM17274 cephalosporinase CMY-31 by spectrophotometry
SummaryPubMed CitationRelated BioAssays by Target
Antimicrobial activity against Salmonella enterica serotype Newport AM17274 expressing CMY-31 cephalosporinase by agar dilution method in presence of Tazobactam
Antimicrobial activity against Salmonella enterica serotype Newport AM17274 expressing CMY-31 cephalosporinase by agar dilution method in presence of clavulanic acid
Antimicrobial activity against Salmonella enterica serotype Newport AM17274 expressing CMY-31 cephalosporinase by agar dilution method
Assay data:10 Tested
Antibacterial activity against quinolone-susceptible Salmonella enterica serovar newport s2099 by agar dilution method
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on